SEC Filing Summary: National Health Investors Inc (NHI)
Business Context and Reporting Period
This Form 8-K was filed on November 5, 2024, by National Health Investors Inc, a Maryland corporation. The filing serves as a Regulation FD disclosure to disseminate an investor presentation and press release titled "NHI Issues Investor Update" to the public. The company's common stock trades on the New York Stock Exchange under the symbol NHI.
Financial Metrics
The provided filing text does not contain specific financial data. It acts as a conduit for information contained in attached exhibits (Exhibit 99.1 and 99.2) rather than reporting direct figures. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this document.
Material Changes
No material changes to financial performance or operations are detailed within the text of this Form 8-K. The filing solely announces the availability of an investor update presentation.
Guidance, Outlook, and Risks
The filing references an investor presentation and press release for management commentary and outlook but does not include the content of those documents. The text explicitly states that the information in the exhibits is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the specific financial metrics and operational updates by accessing Exhibit 99.1 (Press Release) and Exhibit 99.2 (Investor Presentation) referenced in this filing.
- Confirm that the information in the exhibits is not legally incorporated by reference into this Form 8-K for liability purposes under Section 18 of the Exchange Act.
- Note that the Principal Financial Officer, John L. Spaid, signed the report on behalf of the registrant.